| Analytical quality by design approach to test method development and validation in drug substance manufacturing N Raman, UR Mallu, HR Bapatu Journal of chemistry 2015 (1), 435129, 2015 | 107 | 2015 |
| Stability indicating HPLC method for quantification of solifenacin succinate & tamsulosin hydrochloride along with its impurities in tablet dosage form HKR Ganthi, R Reddy, YJ Park, HR Bapatu, SJ Park, WH Cho American Journal of Analytical Chemistry 7 (11), 840-862, 2016 | 33 | 2016 |
| Stability-indicating HPLC method for quantification of celecoxib and diacerein along with its impurities in capsule dosage form HR Bapatu, RK Maram, RS Murthy Journal of chromatographic science 53 (1), 144-153, 2015 | 25 | 2015 |
| QbD approach method development for estimation of dabigatran etexilate along with its impurities and identification of degradants in capsule dosage form HR Bapatu, RK Maram, WH Cho, VBR Pasagadugula American Journal of Analytical Chemistry 7 (6), 494-524, 2016 | 20 | 2016 |
| Development and comparative assessment of hydrocolloid based against wax based gastro retentive bilayered floating tablet designs of atorvastatin calcium using Qbd approach AK Nair, VB Rao, UR Mallu, V Ramana, BH Reddy J Pharm Drug Deliv Res 4 (3), 2015 | 17 | 2015 |
| Impact of API (active pharmaceutical ingredient) source selection on generic drug products UR Mallu, AK Nair, J Sankar, HR Bapatu, MP Kumar, S Narla, TA Bhanap, ... Pharmaceut Reg Affairs 4 (2), 11, 2015 | 15 | 2015 |
| A Validated stability indicating UPLC method for montelukast impurities in montelukast sodium oral granules HR Bapatu, MR Kumar, LK Garg, D Venugopal, AM Reddy International J Pharm Biomed Anal 3 (1), 345-55, 2012 | 13 | 2012 |
| Robust and rugged stability-indicating HPLC method for the determination of plerixafor and its related impurities in drug substances HR Bapatu, RK Maram, RS Murthy Journal of Chromatographic Science 53 (9), 1432-1442, 2015 | 11 | 2015 |
| Quality improvement with scientific approaches (QbD, aQbD and PAT) in generic drug substance development: review HRBNKT Raman VVSSN, Useni Reddy M, Arunkanth Krishnakumar N, Maheshwar Reddy M International Journal of Research and Development in Pharmacy and Life …, 2015 | 9* | 2015 |
| Development and Validation of a Method for Trace Level Zinc Quantification in Pharmaceutical Zinc Supplements Using a Carboxyl Functional Group Packed Column and Refractive … NR Vanga, VR Kesamsetty, K Ummiti, VN Ratnakaram, HR Bapatu Journal of AOAC International 107 (1), 2-13, 2024 | 7 | 2024 |
| Pharmaceutical compositions of nilotinib AK Singh, K Priya, GK Jain, S Jain, HR BAPATU US Patent 10,874,671, 2020 | 6 | 2020 |
| Carobomer based controlled release designs of atorvastatin calcium tablets evaluated using Quality by Design (QbD) approach AK Nair, PV Ramana, PVB Rao, BH Reddy, HKR Ganthi, UR Mallu American Journal of Analytical Chemistry 8 (03), 189, 2017 | 6 | 2017 |
| Pharmaceutical drug products approval procedure in Australia K Anand, UR Mallu, M Kuraku, HR Bapatu Exp 11 (3), 690-705, 2013 | 6 | 2013 |
| Assessment of the Water Sorption Capacity of Rifaximin Using the Dynamic Vapor Sorption Technique for Optimization of the Choice of Excipients and the Manufacturing Environment … NVDP Ketha, HR Bapatu, K Ummiti, PK Subbappa, D Kolli Journal of AOAC International 106 (6), 1464-1470, 2023 | 5 | 2023 |
| Qbd approach high-performance liquid chromatographic technique for determination of clofarabine impurities in clofarabine Api, clofarabine parenteral dosage form and … AR Nekkalapudi, V gopal Veldi, HR Bapatu NVEO-NATURAL VOLATILES & ESSENTIAL OILS Journal| NVEO, 82-98, 2022 | 4 | 2022 |
| Pharmaceutical compositions of testosterone PP SINGH, HR BAPATU, PK Subbappa, AK Singh US Patent 11,311,554, 2022 | 4 | 2022 |
| Development of HPLC Method for Ixabepilone (Oncology Drug) in Bulk and Dosage Form: Quantification of Impurities and Forced Degradation Studies AR Nekkalapudi, S Navuluri, S Pippalla, NK Katari, VK Cholleti, ... Journal of Chromatographic Science 62 (3), 222-231, 2024 | 3 | 2024 |
| API supplier change or addition of alterate API supplier in generic drug products: Cost, quality and regulatory factors UR Mallu, AK Nair, HR Bapatu, M Pavan Kumar, S Narla Pharm Anal Acta 6 (364), 2, 2015 | 3 | 2015 |
| A QBD WITH THE FRACTIONAL FACTORIAL DESIGN WAS USED TO MATCH THE SIMILARITY BETWEEN RANOLAZINE EXTENDED-RELEASE TABLETS 500 MG AND 1000 MG KS SANKARAIAH JONNA, HANIMI REDDY BAPATU, PRAVEEN SUBBAPPA International Journal of Applied Pharmaceutics 15 (2), 98-105, 2023 | 2 | 2023 |
| Enhanced electrocatalytic CO2 reduction into formate: Unleashing the effect of engineered bimetallic oxides supported on activated carbon H Manjunath, C Singh, PM Srinivasappa, K Ravi, AV Biradar, HR Bapatu, ... Applied Surface Science 681, 161468, 2025 | | 2025 |
Praveen SubbappaSenior Director, Slayback Pharma LLC在 slayback-pharma.com 的电子邮件经过验证
